Cargando…

Contribution of CT Features in the Diagnosis of COVID-19

The outbreak of novel coronavirus disease 2019 (COVID-19) first occurred in Wuhan, Hubei Province, China, and spread across the country and worldwide quickly. It has been defined as a major global health emergency by the World Health Organization (WHO). As this is a novel virus, its diagnosis is cru...

Descripción completa

Detalles Bibliográficos
Autor principal: Zuo, Houdong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670585/
https://www.ncbi.nlm.nih.gov/pubmed/33224361
http://dx.doi.org/10.1155/2020/1237418
_version_ 1783610767372713984
author Zuo, Houdong
author_facet Zuo, Houdong
author_sort Zuo, Houdong
collection PubMed
description The outbreak of novel coronavirus disease 2019 (COVID-19) first occurred in Wuhan, Hubei Province, China, and spread across the country and worldwide quickly. It has been defined as a major global health emergency by the World Health Organization (WHO). As this is a novel virus, its diagnosis is crucial to clinical treatment and management. To date, real-time reverse transcription-polymerase chain reaction (RT-PCR) has been recognized as the diagnostic criterion for COVID-19. However, the results of RT-PCR can be complemented by the features obtained in chest computed tomography (CT). In this review, we aim to discuss the diagnosis and main CT features of patients with COVID-19 based on the results of the published literature, in order to enhance the understanding of COVID-19 and provide more detailed information regarding treatment.
format Online
Article
Text
id pubmed-7670585
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-76705852020-11-19 Contribution of CT Features in the Diagnosis of COVID-19 Zuo, Houdong Can Respir J Review Article The outbreak of novel coronavirus disease 2019 (COVID-19) first occurred in Wuhan, Hubei Province, China, and spread across the country and worldwide quickly. It has been defined as a major global health emergency by the World Health Organization (WHO). As this is a novel virus, its diagnosis is crucial to clinical treatment and management. To date, real-time reverse transcription-polymerase chain reaction (RT-PCR) has been recognized as the diagnostic criterion for COVID-19. However, the results of RT-PCR can be complemented by the features obtained in chest computed tomography (CT). In this review, we aim to discuss the diagnosis and main CT features of patients with COVID-19 based on the results of the published literature, in order to enhance the understanding of COVID-19 and provide more detailed information regarding treatment. Hindawi 2020-11-12 /pmc/articles/PMC7670585/ /pubmed/33224361 http://dx.doi.org/10.1155/2020/1237418 Text en Copyright © 2020 Houdong Zuo. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Zuo, Houdong
Contribution of CT Features in the Diagnosis of COVID-19
title Contribution of CT Features in the Diagnosis of COVID-19
title_full Contribution of CT Features in the Diagnosis of COVID-19
title_fullStr Contribution of CT Features in the Diagnosis of COVID-19
title_full_unstemmed Contribution of CT Features in the Diagnosis of COVID-19
title_short Contribution of CT Features in the Diagnosis of COVID-19
title_sort contribution of ct features in the diagnosis of covid-19
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670585/
https://www.ncbi.nlm.nih.gov/pubmed/33224361
http://dx.doi.org/10.1155/2020/1237418
work_keys_str_mv AT zuohoudong contributionofctfeaturesinthediagnosisofcovid19